Raphael Mechoulam

51.9k total citations · 14 hit papers
415 papers, 39.8k citations indexed

About

Raphael Mechoulam is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Raphael Mechoulam has authored 415 papers receiving a total of 39.8k indexed citations (citations by other indexed papers that have themselves been cited), including 323 papers in Pharmacology, 112 papers in Cellular and Molecular Neuroscience and 59 papers in Molecular Biology. Recurrent topics in Raphael Mechoulam's work include Cannabis and Cannabinoid Research (313 papers), Neuroscience and Neuropharmacology Research (69 papers) and Neurotransmitter Receptor Influence on Behavior (65 papers). Raphael Mechoulam is often cited by papers focused on Cannabis and Cannabinoid Research (313 papers), Neuroscience and Neuropharmacology Research (69 papers) and Neurotransmitter Receptor Influence on Behavior (65 papers). Raphael Mechoulam collaborates with scholars based in Israel, United States and Canada. Raphael Mechoulam's co-authors include Yehiel Gaoni, Aviva Breuer, Roger G. Pertwee, Linda A. Parker, Vincenzo Di Marzo, Esther Shohami, William A. Devane, Ester Fride, Dan Gibson and Graeme Griffin and has published in prestigious journals such as Nature, Science and Chemical Reviews.

In The Last Decade

Raphael Mechoulam

409 papers receiving 38.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

1992 4.5k citations William A. Devane, Aviva Breuer et al. profile →
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

1964 1.8k citations Yehiel Gaoni, Raphael Mechoulam profile →
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

2010 1.3k citations Roger G. Pertwee, Allyn C. Howlett et al. profile →
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

2001 1.1k citations Raphael Mechoulam, Vincenzo Di Marzo et al. profile →
The Endocannabinoid System and the Brain

2012 754 citations Raphael Mechoulam, Linda A. Parker profile →
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

2009 630 citations Vincenzo Di Marzo, Raphael Mechoulam et al. profile →
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

2001 601 citations Aviva Breuer, Raphael Mechoulam et al. profile →
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB ₁ receptor

2001 586 citations Aviva Breuer, Zvi Vogel et al. profile →
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

2000 540 citations Ruth Gallily, Raphael Mechoulam et al. profile →
Endocannabinoid signaling at the periphery: 50 years after THC

2015 499 citations Guy A. Cabral, Vincenzo Di Marzo et al. profile →
Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy

2010 416 citations Raphael Mechoulam et al. profile →
Marihuana Chemistry

1970 411 citations Raphael Mechoulam profile →
Hashish—I

1963 361 citations Raphael Mechoulam et al. Tetrahedron profile →
A Total Synthesis of dl-Δ¹-Tetrahydrocannabinol, the Active Constituent of Hashish¹

1965 290 citations Raphael Mechoulam, Yehiel Gaoni profile →

Peers

Countries citing papers authored by Raphael Mechoulam

Since Specialization

Citations

This map shows the geographic impact of Raphael Mechoulam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Mechoulam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Mechoulam more than expected).

Fields of papers citing papers by Raphael Mechoulam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael Mechoulam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Mechoulam. The network helps show where Raphael Mechoulam may publish in the future.

Co-authorship network of co-authors of Raphael Mechoulam

This figure shows the co-authorship network connecting the top 25 collaborators of Raphael Mechoulam. A scholar is included among the top collaborators of Raphael Mechoulam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphael Mechoulam. Raphael Mechoulam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cannabinoid receptors in GtoPdb v.2025.1 2025 ·IUPHAR/BPS Guide to Pharmacology CITE ·Mary E. Abood, Christian C. Felder, Peter J. Greasley, Miles Herkenham, Allyn C. Howlett, George Kunos, Ken Mackie, Raphael Mechoulam, Roger G. Pertwee, Maurice R. Elphick, Vincenzo Di Marzo, S P H Alexander, Francis Barth, Tom I. Bonner, Heather B. Bradshaw, Guy A. Cabral, Pierre Casellas, Ben Cravatt, William A. Devane, Ruth A. Ross	0
2	Antifungal properties of abnormal cannabinoid derivatives: Disruption of biofilm formation and gene expression in Candida species 2024 ·Pharmacological Research ·(unknown), (unknown), (unknown), (unknown), Ronit Vogt Sionov, Doron Steinberg, Raphael Mechoulam, Natalya M. Kogan, Francesca Levi‐Schaffer	1
3	Cannabinoid receptors in GtoPdb v.2023.1 2023 ·IUPHAR/BPS Guide to Pharmacology CITE ·Mary E. Abood, S P H Alexander, Francis Barth, Tom I. Bonner, Heather B. Bradshaw, Guy A. Cabral, Pierre Casellas, Ben Cravatt, William A. Devane, Vincenzo Di Marzo, Maurice R. Elphick, Christian C. Felder, Peter J. Greasley, Miles Herkenham, Allyn C. Howlett, George Kunos, Ken Mackie, Raphael Mechoulam, Roger G. Pertwee, Ruth A. Ross	3
4	Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Raphael Mechoulam, Gal Shoval, Gil Zalsman, Natalya M. Kogan, Aron Weller	7
5	Evaluation of Sex Differences in the Potential of Δ ⁹ -Tetrahydrocannabinol, Cannabidiol, Cannabidiolic Acid, and Oleoyl Alanine to Reduce Nausea-Induced Conditioned Gaping Reactions in Sprague-Dawley Rats 2022 ·Cannabis and Cannabinoid Research ·Erin M. Rock, Cheryl L. Limebeer, Reem Smoum, Raphael Mechoulam, Linda A. Parker	2
6	Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting 2021 ·Cannabis and Cannabinoid Research ·Erin M. Rock, Cheryl L. Limebeer, Roger G. Pertwee, Raphael Mechoulam, Linda A. Parker	20
7	Comparative Evaluation of Combinatory Interaction between Endocannabinoid System Compounds and Poly‐L‐lysine against Streptococcus mutans Growth and Biofilm Formation 2020 ·BioMed Research International ·Mark Feldman, Ronit Vogt Sionov, Reem Smoum, Raphael Mechoulam, Isaac Ginsburg, Doron Steinberg	15
8	Cannabinoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database 2019 ·IUPHAR/BPS Guide to Pharmacology CITE ·Mary E. Abood, S P H Alexander, Francis Barth, Tom I. Bonner, Heather B. Bradshaw, Guy A. Cabral, Pierre Casellas, Ben Cravatt, William A. Devane, Vincenzo Di Marzo, Maurice R. Elphick, Christian C. Felder, Peter J. Greasley, Miles Herkenham, Allyn C. Howlett, George Kunos, Ken Mackie, Raphael Mechoulam, Roger G. Pertwee, Ruth A. Ross	12
9	Does the Endocannabinoid Anandamide Affect Bacterial Quorum Sensing, Vitality, and Motility? 2019 ·Cannabis and Cannabinoid Research ·(unknown), Reem Smoum, Mark Feldman, Raphael Mechoulam, Doron Steinberg	7
10	Role of CB ₂ Receptor in the Recovery of Mice after Traumatic Brain Injury 2018 ·Journal of Neurotrauma ·(unknown), (unknown), (unknown), Liat Avram, Yoram Cohen, Sigal Liraz‐Zaltsman, Raphael Mechoulam, Esther Shohami	24
11	Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol – studies in BV-2 microglia and encephalitogenic T cells 2015 ·Journal of Basic and Clinical Physiology and Pharmacology ·Ana Juknat, Ewa Kozela, Nathali Kaushansky, Raphael Mechoulam, Zvi Vogel	37
12	Cannabis – the Israeli perspective 2015 ·Journal of Basic and Clinical Physiology and Pharmacology ·Raphael Mechoulam	25
13	Are the endocannabinoid-like compounds N -acyl aminoacids neuroprotective after traumatic brain injury? 2015 ·Journal of Basic and Clinical Physiology and Pharmacology ·(unknown), (unknown), Victoria Trembovler, Raphael Mechoulam, Esther Shohami	10
14	<I>Boswellia</I> resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials 2009 ·Journal of Pharmacy and Pharmacology ·Arieh Moussaieff, Raphael Mechoulam	118
15	Δ9-Tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells 2008 ·Acta Oncologica ·(unknown), Tamar Fisher, (unknown), J. Shoham, Ruth Gallily, Raphael Mechoulam, Gad Lavie, Ninette Amariglio, Gideon Rechavi, Amos Toren	47
16	The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling 1995 ·FEBS Letters ·Michael Bayewitch, Tomer Avidor‐Reiss, Rivka Levy, Jacob Barg, Raphael Mechoulam, Zvi Vogel	175
17	Separation of the discriminative stimulus effects of stereoisomers of Δ2- and Δ3-tetrahydrocannabinols in pigeons 1988 ·European Journal of Pharmacology ·Torbjörn U.C. Järbe, Arto J. Hiltunen, Raphael Mechoulam, Morris Srebnik, Aviva Breuer	8
18	ベンゾオキソシンとベンゾオキソニン誘導体中枢神経系作用を有するテルペノフェノールの新しいグループ訂正 1975 ·Journal of Medicinal Chemistry ·(unknown), Raphael Mechoulam, Bernard Loev	4
19	Marijuana ; chemistry, pharmacology, metabolism and clinical effects 1973 ·Academic Press eBooks ·Raphael Mechoulam, Sumner Burstein	131
20	Massenspektroskopie und IHRE anwendung auf strukturelle und stereochemische probleme—LXVIII: Massenspektroskopische untersuchung der inhaltstoffe von haschisch 1965 ·Tetrahedron ·H. Budzikiewicz, (unknown), David A. Lightner, Carl Djerassi, Raphael Mechoulam, Yehiel Gaoni	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact